loading...| Preferred Name |
Penciclovir |
|
| Synonyms |
PENCICLOVIR 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine Penciclovir BRL 39123 BRL-39123 CCRIS 9213 Denavir |
|
| Definitions |
A synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C66337 |
|
| CAS_Registry |
39809-25-1 |
|
| CHEBI_ID |
CHEBI:7956 |
|
| Chemical_Formula |
C10H15N5O3 |
|
| code |
C66337 |
|
| Concept_In_Subset | ||
| Contributing_Source |
FDA |
|
| DEFINITION |
A synthetic acyclic guanine derivative with antiviral activity, mainly used to treat infections from herpes simplex virus (HSV) types 1 and 2. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited. |
|
| FDA_UNII_Code |
359HUE8FJC |
|
| FULL_SYN |
PENCICLOVIR 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- 9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine Penciclovir BRL 39123 BRL-39123 CCRIS 9213 Denavir |
|
| Has_Salt_Form | ||
| label |
Penciclovir |
|
| Legacy Concept Name |
Penciclovir |
|
| Preferred_Name |
Penciclovir |
|
| prefixIRI |
Thesaurus:C66337 |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0164815 |
|
| subClassOf |